ArticleMolecular diagnosis & therapy2019

Combined Fascin-1 and MAP17 Expression in Breast Cancer Identifies Patients with High Risk for Disease Recurrence.

Ekaterini Christina Tampaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.